September 2021 
The Pacific Sickle Cell Regional Collaborative and Networking California for Sickle Cell Care seeks to improve the health and quality of life of individuals with sickle cell disease.
Networking California for Sickle Cell Care: The Center for Inherited Blood Disorders and the Sickle Cell Disease Foundation (SCDF) established a network of sickle cell disease centers in the local health jurisdictions of Alameda, Fresno, Kern, Los Angeles, Sacramento, San Bernardino, and San Diego to provide access to specialty care and improve quality of care for adults with sickle cell disease; support workforce expansion for coordinated health services; conduct surveillance to monitor disease incidence, prevalence, and other metrics; create a public awareness campaign; and provide fiscal oversight of the resources. 
Pacific Sickle Cell Regional Collaborative: The Center for Inherited Blood Disorders (CIBD) and the University of California San Francisco Benioff Children’s Hospital, Oakland (UCSF) are leading the Pacific Sickle Cell Regional Collaborative (PSCRC), which engages expert sickle cell disease (SCD) clinicians, health departments, community-based organizations (CBOs), health professions associations, federal government partners, public health policy, and epidemiology throughout 13 states.  
In this Edition of the Sickle Cell Connections Newsletter, Learn About:
  • PSCRC & NCSCC in the News
  • Clinical Education
  • Advocacy
  • Surveillance
  • Services
  • Clinical Trials
  • Grant Opportunities
  • Resources
  • Regional Team Member Spotlights
  • Sickle Cell Employment Opportunities

New!  Nature released an article, ‘No adult left behind: bridge the health-care gap for sickle-cell disease’ which highlights the reduced child mortality from sickle cell disease but the lack thereof for adults and the need for comprehensive care. This article referenced the funding provided by the state of California for the Networking California for Sickle Cell Care (NCSCC) Initiative. Additionally, Dr. Marsha Treadwell, PSCRC’s CO-PI's comments are included in this article and refer to the need for transition programs for persons with sickle cell disease.

To read this article, click here

New! The Sickle Cell Disease Foundation (SCDF) was featured in an article on Sickle Cell Disease News which highlighted the $1 Million grant to educate SCD patients living in the western U.S. about the COVID-19 vaccine and assisting them in accessing vaccination programs.

To read this article, click here


New!  The UCSF Benioff Children’s Hospital Oakland will be hosting a Sickle Cell Disease Boot Camp in the fall for physicians and advanced practice providers. At this time, the boot-camp date and time is to be determined.  

Please email Beth Anne Martin at to be added to the waitlist.

New! PSCRC Project ECHO (Extension for Community Healthcare Outcomes) is a telementoring series designed for clinical providers to bridge the gap between a network of local providers and pediatric and adult SCD specialists.  The Project ECHO calls occur on a monthly basis as a one-hour video conference that includes case presentation, didactic, and review. 
The next PSCRC Project ECHO Telementoring session: 
Date & Time: Friday, October 15, 2021; 12:00-1:00PM (PST) 
Topic: ED Care in sickle cell disease 
Presented by: Neha Bhasin, MD, UCSF Benioff Children’s Hospital Oakland 

You can register for all upcoming Project ECHO calls and view past recordings directly on the PSCRC website

New! SAPPORT is offering two new opportunities for APPs: 

  • An additional monthly ECHO telementoring series hosted by  of Johns Hopkins University, on the 3rd Thursday of each month 9:00AM-10:00AM, PST 
  • A certificate training program that includes an online curriculum and a 2-4 week observership 

To formally enroll to attend the additional monthly ECHO telementoring session for APPs hosted by Johns Hopkins University OR the training program please register/apply here 



New! Ask Congress to Fund Sickle Cell Research & Awareness! Congresswoman Barbara Lee (D-CA) is leading Congressional efforts to increase awareness and funding for sickle cell, which disproportionally impacts Black and Latino communities. Take action here and join UCSF in asking Congress to support sickle cell research and help ensure access to testing and lifesaving information. Your advocacy is timely as September honors Sickle Cell Awareness Month. Submit your email in support using this customizable template, and find other ways to get involved and support the sickle cell community at

New! California is poised to start what could be the biggest expansion of community health workers in state history. The 2021-22 budget establishes community health worker benefits within the Medi-Cal program, allowing CHWs to be paid for providing benefits and services to Medi-Cal enrollees. 

To read the full article, click here


New! The Sickle Cell Data Collection (SCDC) program, CDC’s SCD surveillance (health monitoring) program has expanded in the past two years and now collects health information from eleven states. Currently, data are available only for California and Georgia.

View California and Georgia data. 

CDC’s SCDC program gathers health information from multiple sources to determine how many people live with the condition in a particular state. The SCDC program helps better understand SCD in five key areas: where people with SCD live, information on transitioning from pediatric to adult care, the challenges of identifying SCD among Hispanic patients, the health problems that patients experience as they age, and the use of healthcare services.  


New! The National Institute for Children's Health Quality (NICHQ) released it's Sickle Cell Disease Treatment Demonstration Program (SCDTDP) 2021 Report to Congress. The Pacific Sickle Cell Regional Collaborative s one of the five SCDTDP regions. 

To view/download the 2021 NICHQ SCD Report to Congress, click here


New!  The U.S. Department of Health and Human Services’ (HHS) Increasing Community Access to Testing (ICATT) Program is partnering with pharmacies nationwide to provide no-cost COVID-19 testing with a focus on vulnerable communities. While the ICATT mission focuses on maximizing testing for vulnerable communities, all testing sites are open to any member of the public. Since April 2020, ICATT has sponsored 14.8 million tests and more than 8,000 pharmacy sites have performed no-cost COVID-19 testing.

State and local public health departments should contact the ICATT program ( to learn more about how ICATT can serve communities and assist during surge situations. For more information, please contact, 


New! Clinical Trial: Sickle Cell Anemia: Therapeutic Response Evaluation and Adherence Trial (TREAT Study). This study, sponsored by the Children's Hospital Medical Center, Cincinnati, seeks children and youth ages 6 months to 21 years old with a diagnosis of sickle cell anemia. The study will be carried out at the Cincinnati Children's Hospital Medical Center in Cincinnati, Ohio. 

To learn more about this clinical trial, click here  


New! Global Blood Therapeutics (GBT) has established The GBT Foundation to fund programs that will support people within the SCD community and beyond through education, empowerment, improved healthcare access and enhanced health equity. The GBT Foundation will fund programs from nonprofit organizations around the world that have the potential to create meaningful and sustainable change, and is currently accepting grant proposals in four core areas of focus:

  •  Increasing SCD education and awareness for communities impacted by SCD to build knowledge of the devastating physical, social, mental and societal effects of this genetic blood disorder.
  • Empowering people with SCD, caregivers and others in the SCD community to help improve the lives and care of the community.
  • Improving access to healthcare in SCD to help those living with SCD receive the high-quality health services they need and deserve.
  • Enhancing health equity through innovative and sustainable solutions that help vulnerable communities have the chance to reach their full health potential without social obstacles. 

New! The Office of Minority Health shared resources to celebrate September, Sickle Cell Awareness Month: 

  • Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action, published by the National Academies of Sciences, Engineering, and Medicine. This report, available for free, discusses disparities in SCD care and provides a strategic framework for the future. To view this title and find additional information, search the online catalog. 

  • Join the National Heart, Lung, and Blood Institute (NHLBI) in observing Sickle Cell Awareness Month 2021 with the overarching theme, "Advancing Sickle Cell Disease Research." To learn more, click here

New! The Centers for Disease Control and Prevention (CDC) Has Many Activities That Use Data to Learn More About SCD, See below for the list of Resources to learn more about sickle cell disease.


  • Aika Aluc, Mei Zhou, Susan T. Paulukonis, Angela B. Snyder, David Wong & Mary M. Hulihan (2020) Using surveillance to determine the number of individuals with sickle cell disease in California and Georgia, 2005–2016, Pediatric Hematology and Oncology, 37:8, 747-751, DOI: 10.1080/08880018.2020.1779886Acute Care Utilization at End of Life in Sickle Cell Disease: Highlighting the Need for a Palliative Approach. 

  • Emily E. Johnston, Oyebimpe O. Adesina, Elysia Alvarez, Heather Amato, Susan Paulukonis, Ashley Nichols, Lisa J. Chamberlain, and Smita Bhatia.Journal of Palliative Medicine.Jan 2020.24-32. 

  • Kayle, M, Valle, J, Paulukonis, S, et al. Impact of Medicaid expansion on access and healthcare among individuals with sickle cell disease. Pediatr Blood Cancer. 2020; 67:e28152. 

  • Payne AB, Mehal JM, Chapman C, Haberling DL, Richardson LC, Bean CJ, Hooper WC. Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017. Ann Emerg Med. 2020 Sep;76(3S):S28-S36. doi: 10.1016/j.annemergmed.2020.08.009. PMID: 32928459; PMCID: PMC7598427. 

  • Wong TE, Valle J, Paulukonis S. Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease. Health Sci Rep. 2021;4(3):e323. Published 2021 Jul 14. doi:10.1002/hsr2.323


Data Briefs:

Fact Sheets:
  • Hospital and Emergency Department Utilization for People with SCD in California and Georgia: Data from the SCDC program was used to look at the number of hospital admissions, emergency department visits, 30-day re-admissions, and payers of this healthcare use


Starting October 2021, we will be highlighting a member from the NCSCC or the PSCRC in this monthly newsletter. We will ask the same questions of each highlighted member and ask for a photo to include in the newsletter. This will allow members to get to know one another more on a professional and personal level by sharing why you do this work, what changes you want to see in the provision of Sickle Cell care, and some fun facts about yourself. When you are selected, you will receive an email from Jolene Bastas from CIBD, so be on the lookout in the coming months. 


Please send any Sickle Cell Disease job openings to Jolene Bastas, MSW, CIBD Project Management Consultant at and they will be disseminated to the listservs of both the PSCRC and NCSCC initiatives. You may also request that they are included in this monthly newsletter. 

If you know someone interested in working in Sickle Cell Disease, please send their resume to Jolene Bastas (information above) to disseminate it amongst both networks. 

Email Priscilla Salceda at by Monday, October 25, 2021 to include your information in the next newsletter.
Copyright © 2021 PSCRC, All rights reserved.
 Pacific Sickle Cell Regional Collaborative

This newsletter is partially supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under U1EMC27862 Sickle Cell Treatment Demonstration Program as part of an award totaling $900,000. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS or the U.S. Government.

Copyright © 2021 NCSCC, All rights reserved.

Networking California for Sickle Cell Care

This project is supported by the California Department of Public Health (CDPH) as part of SB-74 and the Budget Act of 2019. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by the State of California.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Center For Inherited Blood Disorders · 701 S. Parker Street · Suite 100 · Orange, CA 92868 · USA

Email Marketing Powered by Mailchimp